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Validation tools: can they indicate the information content of
macromolecular crystal structures?
EJ Dodson1*, GJ Davies1, VS Lamzin2, GN Murshudov1,3 and KS Wilson1
The explosive increase in the number of published three-
dimensional structures of macromolecules determined by
X-ray analysis places a responsibility on experimentalists,
referees and curators of databases to ensure
correspondence between the structure parameters and data.
Validation tools will evolve as more appropriate statistical
techniques and new information, such as that from proteins
analysed at atomic resolution, becomes available.
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Approximately 2000 new X-ray and NMR structures are
deposited each year and the three-dimensional (3D)
structure is now a prerequisite for full biochemical analy-
sis of a protein. While a proportion of structures are the
result of detailed analysis by experienced crystallogra-
phers, the increasingly automated and routine methods
mean that many are solved rapidly in laboratories without
specialist training in crystallography. At present there is
a strict requirement that the coordinates for all struc-
tures are deposited in the Protein Data Bank (PDB) upon
publication, and in the future the associated data will
also be required. 
This influx of new structures puts a heavy onus for
quality control onto referees and deposition centres [1],
especially as the model will be used by people who may
not have an informed understanding of the techniques of
structure determination. Validation tools for models, such
as PROCHECK [2], WHAT_CHECK [3], SQUID [4] and
PROVE [5], have been and are being developed to identify
mistakes and to assign indicators to reflect the information
content. With the current deposition policy most of the
established validation tools have considered models alone.
These tools utilise geometric and stereochemical criteria
such as bond lengths and 3D conformers, properties also
used to aid structure determination as part of the refine-
ment repertoire. All of these validation tools attempt to give
an overall estimate of accuracy and to provide some residue-
by-residue flag of reliability. These flags can be used to
prevent over-exploitation and to weight analysis of the sta-
tistical norms for stereochemistry. As the practice of data
deposition increases, various laboratories are addressing the
major deficiency in validation software: namely its need to
evaluate the agreement between the derived model and the
experimental data, both in a global and local manner [6].
What is validation?
In the present context, the Oxford English Dictionary
defines ‘to validate’ as ‘to examine data etc. for incorrect-
ness or bias; to confirm or test the suitability of a model’.
We may take this to imply testing by an objective third
party, independent of the person who derived the model.
For protein crystal structures, this is done for two different
purposes. The first should be linked with refereeing, aiming
to assess the quality of work presented and to detect any
errors which will then be reported to the depositor for cor-
rection (i.e. it is an extension of the interpretation and
refinement process). The second is to communicate to
users of the structures what confidence level they should
assign to overall and individual parameters, and what level
of detail may be extracted with confidence. Clear and
simple indicators are needed for this purpose. The ques-
tion is: which are the most appropriate?
Three considerations
In order to answer this question, three factors need to be
taken into consideration. Is the fit between the postulated
model and the experimental data justified? Are the targets
used by the current procedures correct to the best of our
knowledge, and is it valid to assume their distributions are
Gaussian? Is it acceptable to reapply properties used during
refinement as criteria for validation?
To discuss this it is necessary to consider the nature of
crystal structure determination. During the past 50 years,
small molecule crystallography has underpinned our under-
standing of chemistry. Least-squares refinement with an
over-determined model (i.e. many more observations than
parameters, typically ten to one) not only yields accurate
atomic parameters, but assigns estimated standard uncer-
tainties (SUs; Table 1) [7–9]. With this wealth of informa-
tion the SUs themselves, based on the observed data,
provide true ‘validation’ in terms of accuracy and informa-
tion content. The checks required for publication are then
largely clerical.
There are some fundamental differences in macromolecu-
lar crystallography, some of which have importance for vali-
dation. Firstly, for these large molecules, a considerable
proportion of the cell volume is filled with mobile solvent,
the lattice is held together by tenuous contacts and the
periodicity can be imperfect (Figure 1) [10]. Consequently
the diffraction often fades at comparatively low resolution
and even for those crystals which diffract to ‘atomic’ resolu-
tion, the solvent and the residues at the solvent interface
can be poorly ordered and thus not contribute to the high
angle terms. As more macromolecular structures have been
deposited, statistical analysis has yielded a great deal of
information about properties such as expected χ angles and
peptide planarity, although much less about the appropri-
ate SUs ([11] and references therein). This knowledge
guides new structure interpretation and typical procedures
for interpreting maps rest heavily on prior knowledge of
stereochemistry [12,13]. Secondly, as macromolecules are
organic molecules they can be expected to have similar
geometric properties to the high precision small molecules
deposited in the Cambridge Structural Data Base (CSD)
[14]. From these data it is possible to determine, for
example, expected bond lengths, chiral volumes, deviation
from planarity of aromatic rings and their distribution.
Engh and Huber [15] codified the geometric information
for amino acids into dictionaries for XPLOR [16] and these
have since been adapted for other refinement programs.
Finally, the analysis of eight protein structures solved at
atomic resolution by a group of validators and experimen-
talists has provided updated information about the distrib-
ution of stereochemical parameters which will strengthen
the knowledge base used in the dictionaries [11].
Macromolecular refinement programs restrain models to
fit a selection of geometric and stereochemical expecta-
tions. The introduction of these restraint terms used to be
described as ‘extending the number of observations’ [17]
but it is better thought of as finding a model to fit the
experimental data, using all available ‘prior’ knowledge.
Restrained refinement is a natural application of Bayes’s
theorem, which addresses the problem of maximising con-
ditional probability [18] (Figure 2). If the elements are
weighted properly, the model adapts smoothly to fit the
available information (i.e. when high resolution experimen-
tal data are available the prior restraints knowledge is
updated, but at lower resolution the restraints will steer the
model to fit the available data better). Statistical terminol-
ogy describes this as asymptotic behaviour. Unfortunately,
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Figure 1
Packing of the peptide-binding protein Oppa [10]. The crystal
structure is in space group P212121 and is viewed down the b axis,
shown as a Cα trace. The structure is coloured according to B factor:
red indicates a high B factor; dark blue a low B factor.
Table 1
Terms used in structure validation.
Abbreviation Definition Explanation
SU Standard uncertainty Estimated from second derivative matrices. If a quantity is assumed to be Gaussianly distributed,
its SU is the estimated standard deviation of the Gaussian. For parameters determined by least-
squares refinement this can be derived by the inversion of the second derivative matrix multiplied
by the goodness of fit. If L is the likelihood function used for the estimation of the parameters pi,
then – 〈d2 (log L)/dpi dpj 〉–1 is the covariance matrix of the Gaussian approximation to the
distribution of the estimated parameters [7]. The diagonal terms of this matrix give the SUs of the
parameters and the non-diagonal terms the covariance between different parameters.
ADP Atomic displacement Proportional to the conventional atomic B values (ADP = B/8pi2) and is the estimated root mean 
parameter square (rms) coordinate displacement.
Luzzati’s condition Luzzati analysed the distribution of the R factor against resolution for a given model, and showed 
for convergence that this was related to < cos 2pis Dx > where s is the inverse of the resolution squared, and Dx is 
the average coordinate error. When the model is complete and minimisation has reached its 
convergence, D tends to 1, and the distribution should become flat. This does not imply that there is 
no error in the coordinates, just that they fit the available data as well as possible.
DPI Overall dispersion Estimates of the overall rms error have used various formulae. Luzzati plots have been used in the 
precision indicator past but estimates based on σA are more statistically justified but do not reflect well the data 
resolution. Cruickshank suggested a formula which gives more realistic values based on R factor, 
completeness and data resolution [30]. No overall value can be truly adequate as there is a wide 
range of precision present in any structure, roughly proportional to the atomic ADPs. 
estimating correct weights is a major problem, although
maximum likelihood methods can give improved individual
weights for the experimental data [19–21]. This is reflected
in plots of R factor and free R values [22] against resolution.
After refinement these values become flat, demonstrating
Luzzati’s condition [23] for convergence (Table 1; Figure 3)
[20]. There is an assumption, however, that all observations
are independent. This is clearly not true in the presence of
such features as noncrystallographic symmetry (especially
pseudo-symmetry) which occurs fairly frequently. In addi-
tion, the appropriate distributions for some of the restraints
remain unclear. Geometric restraints are reasonably approx-
imated as Gaussians with means and SUs taken from the
CSD. Other stereochemical terms such as multimodal χ
angles, where there is not a single target value, or ω
angles, which can be distorted by the peptide environ-
ment, present a greater problem. This was illustrated by
analysis of the ω angles in 13 atomic-resolution structures,
not all of which are Gaussianly distributed about the mean
of 178 degrees (Figure 4) [24]. A serious flaw in the deriva-
tion of many ‘stereochemical’ target values is that they are
based on structures in the PDB, most of which have been
refined with ill-described restraints and weighting schemes
and where there is no way of extracting an estimate of the
reliability of the parameters. These are likely to introduce
serious bias to the accepted stereochemical norms.
Refinement cycles are alternated with rebuilding into
maps phased from the current model. Stand-alone check-
ing programs [2–5] can identify potential problems which
need further inspection. At this stage graphics programs
such as O, QUANTA and XtalView [25–27] also impose
geometric constraints and restraints. Many can be run in
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Figure 3
The behaviour of R and free R factors versus resolution (a) before and
(b) after maximum-likelihood refinement with REFMAC. Bold lines
show the R factor and the thin lines the free R factor. This structure
had been refined to an R factor of 24% and a free R factor of 34%,
using unweighted least-squares. REFMAC reduced the R factor by 4%
and the free R factor by 6%. The plot shows that the greatest
improvement was obtained within the high-resolution range. The
reason for this is that the fit for the high resolution structure factors
depend on accurate parameters for the atoms, but any improvement at
low resolution will require large-scale movements, or a more complete
description of the model (e.g. more solvent atoms).
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Figure 2
Schematic procedure for structure refinement modelled as Bayesian
estimation. Bayes’s theorem provides a mathematical formulation of how
previous knowledge may be combined with new knowledge. It states
that: posterior distribution = prior distribution× likelihood. The likelihood
function is the function through which the data modifies the prior
knowledge of the model, and represents the information about the model
to be derived from the data. The model is derived from the experimentally
phased map; this is often incomplete and may contain some gross
errors. The inference is the stage at which the decisions are made about
the information that is relevant for testing the model. In most cases
compliance with expected protein geometry will be required. Further
decisions may be needed; for instance should the model be forced to
obey noncrystallographic symmetry. The likelihood function should be set
up at this stage, based on the fit between the observed and calculated
amplitudes. In the refinement stage the model parameters are optimised
using the probability distribution for the prior knowledge, and the
likelihood estimates. Using the second derivative matrix at this stage will
provide error estimates for the model parameters. Finally, the criticism
step assesses the agreement with target geometry and inspects density
maps (weighted by the likelihood function). Any extra information, such
as the Ramachandran plot, not included as a restraint in the refinement
can and should be used as a validation parameter. The result of this
analysis will be a new model and a new cycle of estimation starts. When
the experimentor is satisfied the model is deposited. The referee may
add further criticism, and require re-examination of the model. All
information used to obtain the model (i.e. the experimental data, the
restraints used at both the inference and criticism stage, and the
refinement results) should be deposited. Ideally the model should include
estimated standard uncertainties for its parameters.
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conjunction with a ‘protein health’ analysis, such as the
Oops macros [25], which highlight unusual features at this
most appropriate stage (i.e. when the user is able to check
immediately against the electron density).
Validation tools used at deposition
The PDB has developed a procedure, AutoDep, to guide
the depositor. Once coordinates are dispatched, the PDB
runs WHAT_CHECK and returns a voluminous report.
This reports genuine errors, unusual features which the
depositor should check, and attempts a quality assessment
based on the geometric and stereochemical distributions.
These are difficult to evaluate without consideration of
the refinement protocol; for instance restrained torsion
angle refinement [28] will inevitably give a good distribu-
tion of χ angles. The routine use of validation is a big step
in the right direction, but the output needs to be sum-
marised in a more concise manner and the level of flagging
of ‘outliers’ more finely tuned. Other validation software
should also be utilised by the PDB.
There are certain basic checks for crystallographic errors
required at deposition. Firstly, any non-standard nomen-
clature needs to be corrected for the sake of database users.
Secondly, R factor and free R values should be included.
These are familiar statistics, and ease comparisons
between different depositions. The values should be given
in resolution shells, and include an estimate of data com-
pleteness. Thirdly, a check should be made for ‘bumps’
(i.e. there should be no van der Waals clashes within or
between molecules). These are actually very common and
often result from inadequate treatment of the multiple
conformations. The author often chooses to ignore some
minor clashes but such blatant, even if minor, errors in the
model will inevitably degrade its overall quality and hence
phasing power. The fourth essential check relates to
peptide geometry. The peptide bond is unable to take up
many conformations without steric clashes between the
carbonyl group and the sidechain, illustrated by the
Ramachandran plot [29]. Proteins can accommodate some
outliers, and indeed distortion of the peptide bond often
occurs in the active site of enzymes (Figure 5). If the plot
shows many abnormalities, however, it is essential for the
depositor to provide an explanation, as the great majority of
such features are due to misinterpretations. Fifthly, checks
should be made for the presence of voids. Nature abhors a
vacuum and it is unlikely that there will be many voids
within a structure: their presence may indicate an inade-
quate solvent model [4,5]. Finally, an assessment of atomic
dispersion parameters (ADPs) is required. The tempera-
ture factors for a structure can be converted into the more
intuitive root mean square amplitude of vibration (i.e. the
ADP). These values in Å units should reflect the degree of
surface accessibility (Figure 1).
Current validation procedures address these issues in the
main and enable the depositor to correct previously unde-
tected errors. Additional criteria, such as hydrogen-bonding
patterns and inspection of individual temperature-factor
fluctuations, permit identification of more subtle problems
such as incorrect asparagine, glutamine or histidine orienta-
tions (Figure 6).
Global quality indicators such as those provided by
PROCHECK and WHAT_CHECK should be seen as
detectives; not as a jury. These programs can detect gross
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Figure 4
Anomalies in the ω angle distributions. (a) The histogram of ω angle
distribution for the 13 atomic-resolution structures available in the
PDB. It is clear that the Gaussian curve does not adequately describe
the distribution, and the deviant values at the tails can usually be
explained by external forces, as in the case illustrated in Figure 2. 
(b) The 3Fo–2Fc electron density for the region around Trp48 in the
atomic-resolution structure of Protein G (PDB code 2IGD) [24] with
the model superimposed (green ball-and-stick figure). Additionally
marked are the carbonyl oxygen atoms in the idealised positions where
strict planarity of the peptides (i.e. an ω angle of 180°), have been
artificially imposed (shown in red). Those positions clearly lie out of the
centre of the density, by about 0.3 Å. 
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errors, but they do not provide a ‘sliding scale’ of quality
even at atomic resolution [11]. Ironically, a tight clustering
of geometric properties about the expected mean often
indicates a paucity of experimental observations, and not
necessarily a correct structure.
The future 
It cannot be overstressed that the ‘quality’ of a structure is
founded in the quality of the experimental observations. To
obtain the best structure one must acquire as many experi-
mental observations as possible, measure them as accu-
rately as possible, and then use them all! Any complete
validation must check against these. This is the reason why
deposition must include the experimental data, plus a
description of its multiplicity and quality. It should not be
acceptable for depositors to give R factors based on a subset
of data either by applying a sigma cut-off or by excluding
low-resolution terms. Indeed, omission of data may improve
the R factor but will degrade the model. Statistics (includ-
ing completeness, R factors and free R factors) should be
tabulated for all data in resolution shells.
Precision indicators
More sophisticated techniques are being developed which
attempt to assign estimates to the errors of the model.
Formula such as that based on the Luzzati plot are often
used inappropriately to assign an indicator, despite it
indicating the same level of error for structures solved at
very different resolutions. Cruickshank [30] suggested a
more sensitive measure, using the free R, data complete-
ness and resolution to give a more realistic overall value
(Table 1). It is likely that soon the techniques for analysis
of the second derivative matrix will allow SUs to be
assigned for each parameter [31], replacing the existing
limited overall procedures. Ten Eyck has analysed the
underlying mathematics to show that, even at low resolu-
tion, the second derivative matrix contains the necessary
information to guide the parameterisation and to detect
ill-determined parts of the model [32].
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Figure 5
Ramachandran outliers may reveal interesting chemistry. An alanine
residue is held in a ‘forbidden’ region by a mainchain hydrogen bond to
a critical active-site aspartate in a fungal cellulase. The corresponding
Ramachandran plot is shown in the inset: residues in favourable,
allowed and disallowed regions, are outlined in red, blue and black,
respectively.
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Figure 6
Validation of asparagine, glutamine and
histidine sidechain orientations. This validation
may be performed by both hydrogen-bond
checking and inspection of the relative
temperature factors for the chemically distinct
atoms. The figure shows the example of
Asn138 from Bacillus agaradherans Cel5A
(PDB code 4A3H; G Davies, unpublished
results) with weighted 2Fo–Fc density at 1.6 Å
resolution. (a) The correct orientation — both
OD1 and ND2 function appropriately, as
hydrogen-bond acceptors and donors,
respectively; the B values are ‘normal’. (b) The
incorrect orientation — the hydrogen-bonding
pattern is no longer feasible and the B values
refine to abnormal values, too low for ND2
and too high for OD1. Correct orientations for
asparagine, glutamine and histidine have little
or no effect on global validation indicators but
are vital for correct biochemical interpretation. 
A remaining problem will be to educate the user commu-
nity as to the significance of these error estimates, and to
present structural information more realistically than in
current depositions. For instance, one important piece of
information already available which indicates the accu-
racy of positional parameters is the ADP (temperature or
B factor). This is often ignored, but it is vital that this
information is appreciated and used.
Summary
Some validation of atomic parameters along with their
associated data is essential if the wealth of biological struc-
tural information is to be utilised efficiently, and tools are
being developed to aid the experimentalist, the referee
and the community. These tools are very successful at
detecting model errors, but are unable to provide a sensi-
tive scale of structure quality; such a scale must consider
data as well as the model. Better refinement techniques,
with improved weighting of the restraints, can both opti-
mise the model against the data and should provide rea-
sonable error estimates for each parameter. All techniques
will need to be under continuous development, evolving
as the available information increases. 
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